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Özet
Amaç: Dializin optimal dozu ve sıklığı sorunu, dializ tedavisi alımında en 
önemli sorun başlığı olmuştur. Biz yaşın, bazı hemodiyaliz parametrelerin, 
özellikle üre reduksiyon hızı ile (URR) hemodializ yeterliliği üzerindeki etkisi-
ni değerlendirmeyi ve  bu parametreleri diabetli ve diabetli olmayan hasta-
lar arasında karşılaştırmaya çalıştık. Gereç ve Yöntem: İdame hemodiyaliz te-
davisi alan End-stage (SON EVRE) hastalar dikkate alındı. Üre redüksiyon hızı 
ve boy kilo endeksleri hesaplandı. Bulgular: Tümü 60 kişi olan hastalar (K=21, 
E=39) 44 non-diyabetik hemodiyaliz(F=15, M=29) ve 16 (F=6, M=10) diyabe-
tik hemodiyaliz hastasından oluşmakta idi. Non-diyabetikler ve diyabetikler 
arasında diyaliz yeterliliği açısından, diyabetik grupta düşük değerlerle, dik-
kate değer bir fark gözlendi ve 50 yaşındakilerle ve 50 yaş üstü hastalarda 
daha düşük değerlerle,  kreatinin ve diyaliz yeterliliği açısından önemli bir fark 
gözlendi. Tüm hemodiyaliz hastalarında yaş ve hemodiyaliz yeterliliği arasın-
da önemli bir negatif korelasyon gözlendi, ve aynı zamanda yaş ile serum kre-
atinin arasından dikkate değer bir negatif korelasyon belirlendi. Tartışma: Ya-
şın hemodiyaliz üzerine negatif etkisi daha fazla dikkate alınmalıdır, bu bakış 
açısıyla yaşlı hastalarda sıklıkla gözlenen diyaliz komplikasyonları azaltılabilir.
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Abstract
Aim: The issue of optimal dialysis dose and frequency has been a central 
topic in the delivery of dialysis treatment. We aimed to consider the effects 
of age on some hemodialysis parameters specially dialysis adequacy by urea 
reduction rate (URR) and to compare these parameters between diabetics 
and non diabetic HD(hemodialysis) patients. Material and Method: Patients 
with end-stage renal disease (ESRD), undergoing maintenance hemodialysis 
treatment were considered. The urea reduction rate and body mass index 
were calculated. Results: The total patients were 60 (F=21 M=39), consisting 
of 44 non diabetic hemodialysis patients (F=15 M=29), and 16 diabetic 
hemodialysis patients (F=6 M=10). A significant difference of dialysis 
adequacy between non-diabetics and diabetics was observed with lower 
values in diabetic group and a significant difference of dialysis adequacy and 
creatinine was observed in patients, with ages below and more than 50 years 
old with lower values in older patients. A significant negative correlation of 
age with dialysis adequacy in total hemodialysis patients and a significant 
negative correlation of age with serum creatinine were observed. Discussion: 
The negative effect of age on dialysis adequacy needs more attention to this 
aspect  to reduce the dialysis complications which is frequently observed in 
older patients.
Keywords
Hemodialysis; Age; Urea Reduction Rate; Diabetes Mellitus
Journal of Clinical and Analytical Medicine  | 479
 | Journal of Clinical and Analytical Medicine
Yaş ve Diyaliz Yeterliliği / Age and Dialysis Adequacy 
2
Introduction
Until recently, elderly patients were offered renal replacement 
therapy, either in the acute or chronic stages of their illness [1-
3]. Trends have changed and now over 35% of chronic dialysis 
patients are 65 or older, when starting dialysis therapy [1-6]. 
Currently, there are around one million chronic dialysis patients 
worldwide [3-7]. More than half of these patients are older than 
65 years. For various reasons this is a fast growing population 
[1; 2; 8; 9]. Growing acceptance rates of elderly patients for 
dialysis requires a careful consideration because of their spe-
cific problems during hemodialysis(HD) [10-14]. From the begin-
ning of the dialysis era, the issue of optimal dialysis dose and 
frequency has been a central topic in the delivery of dialysis 
treatment. Because among patients with end-stage renal dis-
ease who are treated with HD, solute clearance during dialysis 
is determinant of mortality and low urea reduction ratios dur-
ing dialysis are associated with increased odds ratios for death 
[13-18]. Many patients enter for regular HD, are older and they 
are prone to some complications of hemodialysis. Patient’s age 
by itself affects the HD procedure and may be complicated by 
the resultant problems, one of which is dialysis efficiency [12-
20]. Low dialysis efficiency may influence nutrition and facili-
tate insidious malnutrition [21-25]. The urea reduction rate is a 
function of the clearance of urea from the blood by the dialyzer, 
the length of the individual dialysis treatment, and the volume 
of distribution of urea in a particular patient [15-20]. There-
fore, the urea reduction rate (URR) is a quantitative measure-
ment of an individual patient’s urea clearance during a single 
HD treatment and can be used as a proxy for the adequacy of 
solute clearance during a treatment [20-26]. Studies showed 
that patients with diabetes had lower concentrations and urea 
reduction rates than non-diabetic patients. Possible factors 
contributing to the lower urea reduction ratios in these patients 
include; compromised blood flow during a dialysis treatment 
as a result of hemodynamic instability, poor flow through the 
vascular access for HD [8-10;27-29], and also women treated 
with  HD may have higher urea reduction ratios and a reduced 
odds ratio of death [27-31]. Based on the above mentioned data 
we conducted a study on maintenance hemodialysis  patients 
(MHPs) to consider the effects of age and also gender on he-
modialysis adequacy by URR and secondly to compare these 
parameters between diabetics and non diabetic HD patients, to 
recognize the adverse effects of age better on HD.
Material and Method
This cross - sectional study was conducted on patients with 
end-stage renal disease (ESRD), who was undergoing mainte-
nance hemodialysis treatment with acetate based dialysate and 
polysulfone membranes. The etiologies of renal failure were di-
abetic nephropathy, hypertension, various glomerular diseases, 
autosomal dominant poly cystic kidney disease(ADPKD) and also 
urinary tract infections [32-38].According to the severity of sec-
ondary hyperparathyroidism, each patient was treated with oral 
active vitamin D3 (Rocaltrol), calcium carbonate, and Rena-Gel 
capsules at various doses. According to the severity of anemia, 
patients were treated with IV iron therapy Iron Source (venofer) 
at various doses after each dialysis session .All patients were 
under treatments of 6 mg folic acid daily, oral vitamin B-com-
plex tablet daily and also 2000 U IV Eprex (recombinant human 
erythropoietin (rHuEPO) were given to each patient after each 
dialysis session routinely[39-41]. Exclusion criteria were active 
or chronic infection. For patients predialysis BUN and creatinine 
and post dialysis BUN were measured. The urea reduction ra-
tio is calculated with the formula 100 × (1 - [Ct/Co]), in which 
Ct is the blood urea nitrogen measured five minutes after the 
end of dialysis and Co is the blood urea nitrogen measured five 
minutes after the end of dialysis and Co is the predialysis blood 
urea nitrogen [42]. Body mass  index (BMI) is calculated using 
the standard formula [postdialyzed weight in kilograms/height 
in square meters, kg/m2 . Duration and the amount of sessions 
of HD treatment were calculated from the patient’s records. The 
duration of each HD session was 4 hours. Results are expressed 
as the mean ± SD. Comparison between the groups was done 
using Student’s t-test. Statistical correlations were found by 
using partial correlation test. Statistic analysis was performed 
on total hemodialysis (HD), females, males, diabetics and non 
diabetic’s populations separately. All statistical analysis were 
performed using SPSS (version 11.5.00). Statistical significance 
was determined at a p-value < 0.05.
Results 
The total patients were 60 (F=21, M=39), consisting of 44 non 
diabetics HD  patients (F=15, M=29), and 16 diabetic HD  pa-
tients (F=6, M=10). Table 1 shows patients demographic data. 
Mean±SD of age of total patients were 46±18 years. The length 
of the time patients had been on HD  were 46±18 months. The 
URR of total patients were 57.4±9%. Mean ± SD of URR of dia-
betic group and non-diabetic group were 52.3±9.5 and 59.3±8% 
respectively. Predialysis serum creatinine of total patients was 
9±3.6 mg/dL. In this study no significant differences of age, 
BMI, duration and sessions of HD , and URR between males and 
Table 1. Mean ±SD , Minimum and maximum of age, duration, dose and also  
URR  of  total, nondiabetic and diabetic hemodialysis patients
Total patients n = 60 Minimum Maximum Mean±SD
Age years 11 80 46 ±18
DH* months 2 156 25±30
Dialysis dose sessions 18 1584 219±321
URR            % 39 76 57.4±9
BMI        kg/m2 16 38 22±4.5
Creatinine     mg/dL 1.5 18. 9±3.6
Nondiabetics  n = 44 Minimum Maximum Mean±SD
Age            years 11 80 42.9±18
DH*          months 2 156 29.8±35
Dialysis dose sessions 18 1584 258±367
URR         % 47 76 59.3±8
BMI        kg/m2 16 33 20.6±3.8
Creat      mg/dL 1.5 16 9.5±3.3
Diabetics  n = 16 Minimum Maximum Mean±SD
Age            years 27 79 54±16.7
DH*          months 6 24 13±6
Dialysis dose  sessions 54 216 114±52
BMI        kg/m2 39 75 52.3±9.5
BMI          index 20 38 24.7±5
Creat      mg/dL 3 18 8. ±4.3
*Duration of HD  treatment
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females were found (p = N.S.). A significant difference of URR 
between diabetics and non diabetic HD patients was seen (p = 
0.006). Significant differences of URR (p = 0.007) and creati-
nine (p = 0.024) between patients with age less than and more 
than 50 years were seen. Also a significant negative correlation 
of age with URR in total HD patients was found (r = -0.32, p 
= 0.014). A significant negative correlation of age with serum 
creatinine was seen (r=-0.36, p=0.005) (adjusted for duration of 
HD treatment for two correlations).
Discussion 
In this study we found a significant difference of dialysis ade-
quacy between non-diabetics and diabetics with lower values in 
diabetic group and a significant difference of dialysis adequacy 
and creatinine was observed in patients with age below and 
more than 50 years old, with lower values in older patients. A 
significant negative correlation of age with dialysis adequacy 
in total HD patients and a significant negative correlation of 
age with serum creatinine were seen. In a study conducted by 
Letourneau et al. [43] on ESRD patients with a total of 429 new 
chronic dialysis patients - 67 ESRD patients were over 75 years 
old and 66 patients were between 50 and 60 years old. It was 
found that life expectancy of the patients who began dialysis 
above 75 years old was significantly shorter than the patients 
who started dialysis between 50 and 60 years of age, espe-
cially if they had low weight, lost weight loss and/or required 
hospitalization [43]. Negative association of age with dialysis 
efficiency seriously influences the life expectancy of older pa-
tients [1-6]. We showed the negative association of age and 
predialysis serum creatinine. We also showed a significant lower 
predialysis serum creatinine in patients older than 50 years old 
which suggests insidious malnutrition in these patients might 
become more aggravated with their lower dialysis efficacy. Pre-
vious studies was also attested our findings (4, 6). In contrast 
to our findings no significant difference of dialysis adequacy 
between males and females were found, in a study with  18, 
144 black and  white patients receiving hemodialysis 3 times 
weekly. Owen et al. (44) showed that men had lower URRs’ than 
women, which needs more work in this aspect of hemodialysis 
treatment (44). In conclusion we showed the important nega-
tive effect of age on dialysis adequacy. More attention on this 
aspect is needed for older hemodialysis patients to reduce this 
complications.
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